Scientific Posters & Presentations

May 16, 2024

PES 2024 Poster Presentation – Long Term Safety of DCCR 64 KB

Oct 11, 2023

FPWR Research Conference 2023 798.6 KB

Jun 13, 2022

ENDO 2022 Poster Presentation 390.3 KB

May 22, 2022

Comparison of hyperphagia and problem behaviors in participants with Prader-Willi syndrome (PWS) receiving Diazoxide Choline Extended-Release (DCCR) with matched participants in PATH for PWS (PfPWS) 2.3 MB

May 05, 2021

A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Resting Energy Expenditure (REE) and Adiposity 202 KB

May 05, 2021

Evaluation of Methods That Estimate Glomerular Filtration Rate in Patients With Prader-Willi Syndrome 170 KB

May 05, 2021

Abstract 2739 Therapeutic Response to DCCR (Diazoxide Choline) Extended-Release Tablets in Patients with Prader-Willi Syndrome 116.5 KB

May 04, 2021

Application of a semi-automated framework to characterize individual experiences with DCCR in Prader-Willi syndrome 318.8 KB

Feb 04, 2021

Key Opinion Leader Meeting on DCCR for Treatment of Prader-Willi Syndrome 1.9 MB

Nov 03, 2020

A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Body Composition and Adipokines 636 KB

Jun 08, 2020

Soleno Therapeutics Phase III DESTINY PWS Trial Results 410.2 KB

Nov 15, 2018

DCCR Fat Loss Poster Presentation at Obesity Society November 2018 215.5 KB

Oct 04, 2018

DCCR Mode of Action Oral Presentation at FPWR October 2018 2.4 MB

Oct 04, 2018

DCCR Overall Safety Poster Presentation at FPWR October 2018 96 KB

Sep 29, 2018

DCCR Pharmacokinetics -Poster Presentation at ESPE 2018.pdf 205.9 KB

Sep 29, 2018

DCCR Glycemic Impact - Poster Presentation at ESPE 2018 510.7 KB

Sep 14, 2017

DCCR in PWS – Poster Presentation at the 10th International Meeting of Pediatric Endocrinology 500.5 KB

P1-1161 Efficacy and Safety of Diazoxide Choline Controlled-Release Tablet in Patients with Prader-Willi syndrome, an Updated An 670.6 KB